About Juno Bio
Juno Bio is a company based in London (United Kingdom) founded in 2018 by Hana Janebdar. Juno Bio has raised $3.8 million across 3 funding rounds from investors including Illumina, Pink Salt Ventures and AI Seed. The company has 5 employees as of June 30, 2021. Juno Bio operates in a competitive market with competitors including Atlas Biomed, OMED Health, Nylos and Biomesight, among others.
- Headquarter London, United Kingdom
- Employees 5 as on 30 Jun, 2021
- Founders Hana Janebdar
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Juno Bio Limited
- Date of Incorporation 11 Jun, 2018
- Jurisdiction LONDON, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.8 M (USD)
in 3 rounds
-
Latest Funding Round
$3.8 M (USD), Series A
Jul 16, 2026
-
Investors
Illumina
& 5 more
-
Employee Count
5
as on Jun 30, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Juno Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Juno Bio
Juno Bio has successfully raised a total of $3.8M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $3.8 million completed in July 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Juno Bio
Juno Bio has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Illumina, Pink Salt Ventures and AI Seed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage investments are provided to female-led technology companies.
|
Locked | Locked | Locked | |
|
AI Seed is recognized as a leading AI venture capital fund in Europe.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Juno Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Juno Bio
Investment portfolio details for Juno Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Juno Bio
Detailed financials for Juno Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Juno Bio Comparisons
Peer comparison for Juno Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Juno Bio
Juno Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Atlas Biomed, OMED Health, Nylos and Biomesight, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genetic tests are offered via DNA and gut microbiome analysis.
|
|
| Locked | Locked | Locked |
Offers at-home breath testing and treatment for digestive health conditions.
|
|
| Locked | Locked | Locked |
Offers online gut microbiome testing for personalized diet planning.
|
|
| Locked | Locked | Locked |
Offers gut microbiome analysis, testing kits, and personalized supplement recommendations.
|
Detailed competitors of Juno Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Juno Bio
Complete news archive for Juno Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Juno Bio
Juno Bio was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Juno Bio is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Hana Janebdar is the current CEO of Juno Bio. They have also founded this company.
Juno Bio is a funded company, having raised a total of $3.8M across 3 funding rounds to date.
As of Jun 30, 2021, the latest employee count at Juno Bio is 5.
Juno Bio was established in 2018 and is based in London, United Kingdom. Operations are centered in the biotechnology sector, with a focus on microbiome research. Services encompassing microbiome analysis and related scientific investigations are offered to support client needs. The company is led by Co-Founder and CEO Hana Janebdar, emphasizing factual advancements in microbial studies within a global context.
Juno Bio's top competitors include Atlas Biomed, OMED Health and Nylos.
Juno Bio has 6 investors. Key investors include Illumina, Pink Salt Ventures, AI Seed, Ada Ventures, and Artesian.